Association between kras mutation, detected in pancreatic cyst fluid, and long-term outcomes of patients

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 4, 2013, Pages 425-429

  Rockacy, Matthew J ^a   Zahid, Maliha ^a,b   McGrath, Kevin M ^a   Fasanella, Kenneth E ^a   Khalid, Asif ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Excela Health Cardiology   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CEA; IPMN; Mucinous Cysts; Pancreatic Cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN;

AGED; ARTICLE; BENIGN TUMOR; CANCER MORTALITY; CANCER SURGERY; CLINICAL FEATURE; CODON; CONTROLLED STUDY; CYST FLUID; CYTOLOGY; DISEASE COURSE; DNA DETERMINATION; DNA SEQUENCE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUCINOUS CYSTIC NEOPLASM; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS CYST; PANCREAS PSEUDOCYST; PANCREAS SURGERY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CYST FLUID; DNA; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC CYST; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84875367049     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.008     Document Type: Article

References (24)

1. Brugge W.R., Lauwers G.Y., Sahani D., et al. Cystic neoplasms of the pancreas. N Engl J Med 2004, 351:1218-1226.
2. Kobari M., Egawa S., Shibuya K., et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999, 134:1131-1136.
3. Salvia R., Fernández-del Castillo C., Bassi C., et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004, 239:678-687.
4. Sohn T.A., Yeo C.J., Cameron J.L., et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004, 239:788-799.
5. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003, 90:1244-1249.
6. Khalid A., Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 2007, 102:2339-2349.
7. Tanaka M., Chari S., Adsay V., et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
8. Fernández-del Castillo C., Targarona J., Thayer S.P., et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003, 138:427. 423, discussion 433-434.
9. Irie H., Yoshimitsu K., Aibe H., et al. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 2004, 28:117-122.
10. Pelaez-Luna M., Chari S.T., Smyrk T.C., et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007, 102:1759-1764.
11. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004, 126:1330-1336.
12. Cizginer S., Turner B., Bilge A.R., et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011, 40:1024-1028.
13. Ahmad N.A., Kochman M.L., Lewis J.D., et al. Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?. Am J Gastroenterol 2001, 96:3295-3300.
14. Procacci C., Biasiutti C., Carbognin G., et al. Characterization of cystic tumors of the pancreas: CT accuracy. J Comput Assist Tomogr 1999, 23:906-912.
15. Khalid A., McGrath K.M., Zahid M., et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005, 3:967-973.
16. Khalid A., Zahid M., Finkelstein S.D., et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009, 69:1095-1102.
17. Attasaranya S., Pais S., LeBlanc J., et al. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts. JOP 2007, 8:553-563.
18. Pais S.A., Attasaranya S., Leblanc J.K., et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol 2007, 5:489-495.
19. Crippa S., Salvia R., Warshaw A.L., et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008, 247:571-579.
20. Grobmyer S.R., Cance W.G., Copeland E.M., et al. Is there an indication for initial conservative management of pancreatic cystic lesions?. J Surg Oncol 2009, 100:372-374.
21. Tanno S., Nakano Y., Nishikawa T., et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008, 57:339-343.
22. Sadakari Y., Ienaga J., Kobayashi K., et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010, 39:232-236.
23. Walsh R.M., Vogt D.P., Henderson J.M., et al. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery 2008, 144:677-685.
24. Maguchi H., Tanno S., Mizuno N., et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas 2011, 40:364-370.